Sustainable Insight Capital Management LLC increased its stake in Humana Inc. (NYSE:HUM – Free Report) by 23.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 24,757 shares of the insurance provider’s stock after buying an additional 4,740 shares during the period. Humana accounts for about 2.1% of Sustainable Insight Capital Management LLC’s holdings, making the stock its 16th largest holding. Sustainable Insight Capital Management LLC’s holdings in Humana were worth $6,341,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. Capital International Investors grew its stake in shares of Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after buying an additional 3,097,571 shares during the last quarter. Norges Bank purchased a new stake in shares of Humana in the 4th quarter worth approximately $456,632,000. Franklin Resources Inc. grew its stake in shares of Humana by 914.5% in the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock worth $321,613,000 after buying an additional 1,131,893 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after buying an additional 1,008,514 shares during the last quarter. Finally, Neuberger Berman Group LLC grew its stake in shares of Humana by 2,855.5% in the 3rd quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider’s stock worth $138,092,000 after buying an additional 512,816 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on HUM. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. Bank of America increased their price target on shares of Humana from $267.00 to $340.00 and gave the company a “neutral” rating in a report on Thursday, June 4th. Seaport Research Partners cut shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. Robert W. Baird cut their target price on Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Finally, Truist Financial increased their target price on Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average price target of $291.35.
Humana Stock Performance
Shares of HUM opened at $369.35 on Friday. The business’s fifty day simple moving average is $263.86 and its two-hundred day simple moving average is $236.20. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $372.70. The company has a market cap of $44.34 billion, a price-to-earnings ratio of 39.50, a P/E/G ratio of 2.08 and a beta of 0.76.
Humana (NYSE:HUM – Get Free Report) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period last year, the business posted $11.58 EPS. The company’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Research analysts anticipate that Humana Inc. will post 9.03 earnings per share for the current fiscal year.
Humana Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.
Key Humana News
Here are the key news stories impacting Humana this week:
- Positive Sentiment: Humana agreed to divest all or substantially all of its minority stake in Gentiva, a hospice and palliative care provider, in a deal valuing the stake at about $900 million. Investors may view the sale as a move to sharpen focus on Humana’s core health insurance business and unlock cash for general corporate purposes. Humana Announces Agreement to Divest Minority Interest in Gentiva
- Positive Sentiment: Analyst sentiment also improved, with Evercore raising its price target on Humana to $370 from $250 and implying the shares have room to run from recent levels. Higher targets can reinforce confidence that the stock’s recent momentum is justified. Evercore raises price target on Humana to $370
- Neutral Sentiment: Additional commentary highlighted Humana as a “turnaround” idea, with Mizuho also raising its price target. While not a company-specific catalyst on its own, it adds to the improving investor narrative around the name. 5 Best Turnaround Stocks to Buy in 2026
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
